Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Seagen announces long-term results from Tukysa pivotal trial for HER2-positive breast cancer during the 2021 ASCO Annual Meeting

Written by | 11 Jun 2021

Seagen Inc. announced that improvements in overall survival (OS) and progression-free survival (PFS) were maintained with long-term follow up from the pivotal HER2CLIMB trial evaluating the addition of… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.